Current News

	Search for:		in:

Target:

Full text

Title

Company name

Division:

Country:

From:

To:

Operation:		OR		AND
Search for:		partial		exact

Overview

Companies

Countries

Amgen Completes Acquisition of Avidia

26 Oct 2006 - Amgen announced the completion of the acquisition of Avidia, a privately held biopharmaceutical company that discovers and develops a new class of human therapeutic known as Avimer(TM) proteins. The transaction provides Amgen with Avidia's lead product candidate, an inhibitor of interleukin 6 (IL-6) for the treatment of inflammation and autoimmune diseases, which is in Phase 1 clinical trials.

�

Additional information

Amgen Inc.
Thousand Oaks, CA, United States of America

Company

Buyer's Guide entry of Amgen Inc.

�

News

	22 Sep 2008 -	AMT Obtains License to Amgen�s GDNF Gene to Develop Treatment for Parkinson�s Disease
	19 Sep 2008 -	Three Rivers Pharmaceuticals Obtains Additional Commercial Rights to Infergen from Amgen
	15 Apr 2008 -	U3 Pharma achieves preclinical proof of concept for U3-1287 (AMG 888)
�more news